Aspects of design and statistical analysis in the Comet assay.

Mutagenesis

AstraZeneca R&D Södertälje, S-151 85 Södertälje, Sweden.

Published: March 2003

Some aspects of the statistical design and analysis of the Comet (single cell gel electrophoresis) assay have been evaluated by means of a simulation study. The tail length and tail moment were selected for the quantification of DNA migration. Results from the simulation study showed that the choice of measure to summarize the cells on each slide is extremely important in order to facilitate an efficient analysis. For tail moment, the mean of log transformed data is clearly superior to the other evaluated measures, whereas using the mean of raw data without transformation can lead to very inefficient analyses. The 90th percentile, capturing the upper tail of the distribution, performs well for the tail length, with a slight improvement obtained by applying a log transformation prior to calculations. Furthermore, the simulation study has been used to assess the appropriateness of some models for statistical analysis and to address the issue of design (i.e. number of cultures or animals in each group, number of slides per animal/culture and number of cells scored per slide). Combining the results from the simulations with practical experience from the pharmaceutical industry, we conclude the paper by providing concise recommendations regarding the design and statistical analysis in the Comet assay.

Download full-text PDF

Source
http://dx.doi.org/10.1093/mutage/18.2.167DOI Listing

Publication Analysis

Top Keywords

statistical analysis
12
analysis comet
12
simulation study
12
design statistical
8
comet assay
8
tail length
8
tail moment
8
analysis
5
tail
5
aspects design
4

Similar Publications

Background And Aims: Data on second generation basal insulin (2BI) in people with type 2 diabetes (T2D) generated by clinical trials still need confirmation in real-world clinical settings. This study aimed at assessing the comparative effectiveness of 2BI [Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (Deg-100)] in T2D Italian patients switching from first generation basal insulins (1BI).

View Article and Find Full Text PDF

Background: This study aims to investigate the predictive value of biological and neuroimaging markers to determine incident frailty among older people for a period of 5 years.

Methods: We included 1394 adults aged 70 years and older from the Multidomain Alzheimer Preventive Trial, who were not frail at baseline (according to Fried's criteria) and who had at least 1 post-baseline measurement of frailty. Participants who progressed to frailty during the 5-year follow-up were categorized as "incident frailty" and those who remained non-frail were categorized as "without frailty.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!